PARD Dividend: Poniard Pharmaceuticals Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

PARD Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2010	12/31/2009	12/31/2008	12/31/2007	12/31/2006
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	13	17	14	15	13	7
Research & Development	1	7	25	33	22	13
Operating Expenses	14	25	40	49	35	20
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-16	-30	-45	-48	-32	-23
Income Tax Expense	0	0	0	0	0	0
Net Income	-16	-30	-46	-49	-33	-23
Net Income Growth	-57.99%	-35%	-6%	48%	43%	10%
Shares Outstanding (Diluted)	1.49	1.17	0.88	0.86	0.76	0.43
Shares Change (YoY)	24%	33%	2%	13%	77%	210%
EPS (Diluted)	-10.83	-26.28	-52.4	-56.58	-43.27	-54.77
EPS Growth	-66%	-50%	-7%	31%	-21%	-64%
Free Cash Flow	-10	-24	-35	-33	-30	-22
Free Cash Flow Per Share	-6.67	-20.48	-39.69	-38.05	-39	-50.64
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-13	-24	-39	-48	-34	-20
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	1	1	1	1	1	0
EBIT	-14	-25	-40	-49	-35	-20
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	0%	0%	0%	0%	0%	0%